查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1801208

2025 年至 2033 年免疫血液學市場規模、佔有率、趨勢及預測（按產品、技術、應用、最終用戶和地區）

Immunohematology Market Size, Share, Trends and Forecast by Product, Technology, Application, End-User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球免疫血液學市場規模達20億美元。展望未來， IMARC Group預測，到2033年，該市場規模將達到29億美元，2025-2033年期間的複合年成長率為4%。北美目前佔據市場主導地位，2024年將佔據超過40.2%的市場。該地區的主導地位得益於先進的醫療基礎設施、強大的行業影響力、創新技術的廣泛採用以及對研發的大量投資。

免疫血液學市場的主要驅動力在於，慢性病盛行率的上升和外科手術數量的增加，推動了對先進血液檢測和相容性解決方案的需求不斷成長。這些因素加劇了對可靠的血型鑑定、交叉配血和抗體檢測的需求，以確保患者在輸血和移植過程中的安全。此外，自動化分析儀和分子診斷等免疫血液學技術的進步提高了檢測的準確性和效率，進一步加速了其在醫療保健領域的應用。例如，賽默飛世爾科技於2024年推出了用於疾病和藥物基因組學研究的Axiom PangenomiX Array。它整合了SNP基因分型、全基因組拷貝數檢測、血液和HLA分型功能。它專為疾病風險、血統、健康和藥物開發而設計，包含PGx標記和致病變異。此陣列增強了全基因組填補能力，並具有高度的多樣性，可用於檢測不同種族，使其適用於多樣化的基因研究。新興市場的醫療保健基礎設施不斷擴大以及人們對安全輸血實踐的認知不斷提高也促進了該市場的持續成長。

美國是免疫血液學市場的關鍵參與者，得益於其先進的醫療基礎設施、強勁的研發投入以及對精準診斷的旺盛需求。美國擁有領先的免疫血液學設備和試劑製造商和供應商，這使得自動化分析儀和分子診斷等創新技術能夠迅速普及。例如，貝克曼庫爾特於2024年推出了DxC 500i臨床分析儀，該分析儀結合了化學和免疫分析功能，為醫院和實驗室提供高效、可交換的結果，從而改善了患者護理、營運模式和庫存管理。此外，嚴格的監管標準和完善的血庫系統確保了血液相容性測試的可靠和高效。慢性病的日益普及和人口老化進一步增強了對免疫血液學解決方案的需求，使美國成為該領域發展的關鍵市場。

免疫血液學市場趨勢：

血液疾病盛行率不斷上升

隨著全球白血病和其他血液疾病病例的增加，市場正在經歷巨大的成長。發展中國家醫療保健基礎設施的發展以及血庫和創傷中心的建立也推動了這一成長。據世界銀行稱，2023 年，169 個國家的約 13,300 個血液中心報告共收集了 1.06 億份捐血。這些中心收集的捐血數量因收入群體而異。在低收入國家，每個中心每年的捐血中位數為 1,300 份，而在中低收入國家為 4,400 份，在中高收入國家為 9,300 份。相較之下，高收入國家報告每個中心每年的捐血中位數為 25,700 份。隨著大眾對血液採集、處理、檢測和儲存活動的認知的提高，進一步增加了對免疫血液學設備的需求。

先進診斷技術的採用日益增多

免疫血液學市場正經歷顯著成長，這得益於分子檢測和自動血型分型系統等先進診斷技術的整合。這些新一代免疫血液學設備有助於提高診斷效率，減少分析時間並降低人為錯誤風險因素，並為患者提供即時照護服務。自動化系統簡化了交叉配血和抗體篩檢等流程，這些流程對於輸血安全至關重要。例如，QuidelOrtho 的 VITROS 梅毒檢測試劑盒於 2024 年獲得 FDA 批准，可在 VITROS 系統（3600、5600、XT 7600）上自動檢測梅毒螺旋體抗體，該系統現已在全球範圍內上市，增強了傳染病診斷能力。此外，分子診斷技術可以進行精確的基因分型，有助於識別傳統方法可能忽略的稀有血型和抗體。醫療保健提供者擴大採用這些技術，以滿足對高品質快速診斷解決方案日益成長的需求，尤其是在醫療基礎設施支援先進設備的已開發市場。

擴大對個人化醫療和罕見血液疾病的關注

免疫血液學市場的另一個新興趨勢是越來越重視個人化醫療，尤其是針對罕見血液疾病患者。基因組研究的進展為個人化治療和精準輸血實踐鋪平了道路。識別獨特的抗原譜和罕見表現型正變得越來越重要，尤其是在人口結構多樣化的地區。例如，2024年，臨床階段放射性藥物公司CU6正在利用其SAR技術平台推進下一代診療產品。該公司發表了COBRA研究的I/II期臨床試驗資料，結果令人鼓舞。該試驗證實，其銅基顯影劑I64Cu-SAR-bisPSMA在檢測生化復發患者的前列腺癌病灶方面安全且有效率。透過將標靶成像與治療功能相結合，該技術可以提高診斷準確性，並實現免疫血液學的個人化治療策略。隨著人們對罕見血液疾病認知的提高，對專業免疫血液學產品和服務的需求預計將成長，凸顯了該市場在精準醫療中日益成長的作用。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球免疫血液學市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 分析系統
  • 試劑和耗材

第7章：市場區隔：依技術

  • 生物晶片
  • 凝膠卡
  • 微孔板
  • 聚合酶鍊式反應
  • 紅血球磁化技術（EMT）
  • 其他

第 8 章：市場區隔：按應用

  • 血液相關疾病
  • 愛滋病
  • 肝炎
  • 輸血
  • 其他

第9章：市場區隔：依最終用戶

  • 醫院
  • 血庫
  • 診斷實驗室
  • 其他

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 11 章：SWOT 分析

第 12 章：價值鏈分析

第 13 章：波特五力分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott
    • Antisel
    • BD (Becton Dickinson and Company)
    • Beckman Coulter Inc. (Danaher Corporation)
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche Ltd.
    • Grifols SA
    • Merck KGaA
    • MTC Invitro Diagnostics AG
    • Ortho-Clinical Diagnostics Inc (The Carlyle Group)
    • Siemens Healthcare GmbH
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A2256

The global immunohematology market size was valued at USD 2.0 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 2.9 Billion by 2033, exhibiting a CAGR of 4% during 2025-2033. North America currently dominates the market, holding a significant market share of over 40.2% in 2024. This region's dominance is driven by advanced healthcare infrastructure, strong industry presence, high adoption of innovative technologies, and significant investments in research and development.

A major driver of the immunohematology market is the increasing demand for advanced blood testing and compatibility solutions driven by the rising prevalence of chronic diseases and the growing volume of surgical procedures. These factors have heightened the need for reliable blood typing, cross-matching, and antibody detection to ensure patient safety during transfusions and transplants. Additionally, advancements in immunohematology technologies, such as automated analyzers and molecular diagnostics, have improved testing accuracy and efficiency, further accelerating adoption in healthcare settings. For instance, in 2024, Thermo Fisher Scientific launched the Axiom PangenomiX Array for disease and pharmacogenomics research. It integrates SNP genotyping, whole-genome copy number detection, blood, and HLA typing. Designed for disease risk, ancestry, wellness, and drug development, it includes PGx markers and pathogenic variants. The array offers enhanced whole-genome imputation and high diversity for testing various ethnicities, making it suitable for diverse genetic research. Expanding healthcare infrastructure in emerging markets and growing awareness of safe blood transfusion practices also contribute to the sustained growth of this market.

The United States is a key player in the immunohematology market, driven by its advanced healthcare infrastructure, robust research and development initiatives, and a high demand for precision diagnostics. The country is home to leading manufacturers and suppliers of immunohematology equipment and reagents, enabling rapid adoption of innovative technologies such as automated analyzers and molecular diagnostics. For instance, in 2024, Beckman Coulter launched DxC 500i Clinical Analyzer, combining chemistry and immunoassay capabilities, delivering efficient, commutable results for hospitals and labs, enhancing patient care, operational models, and inventory management. Additionally, stringent regulatory standards and well-established blood banking systems ensure reliable and efficient blood compatibility testing. The growing prevalence of chronic diseases and an aging population further enhance the demand for immunohematology solutions, positioning the US as a pivotal market for advancements in this sector.

Immunohematology Market Trends:

Increasing Prevalence of Hematological Disorders

With the increasing instances of leukemia and other hematological disorders across the world, the market is witnessing immense growth. Developments in the healthcare infrastructure and the establishment of blood banks and trauma centers in developing countries are also motivating this growth. According to the World Bank, in 2023, approximately 13,300 blood centers across 169 countries reported collecting a total of 106 Million donations. The number of donations collected at these centers varies by income group. In low-income countries, the median annual donations per center was 1,300, while in lower-middle-income countries it was 4,400, and in upper-middle-income countries, it was 9,300. In comparison, high-income countries reported a median of 25,700 donations per center annually. With this increase in mass awareness concerning the activities involved in blood collection, processing, testing, and storage, it further enhances the demand for immunohematology devices.

Rising Adoption of Advanced Diagnostic Technologies

The immunohematology market is experiencing significant growth driven by the integration of advanced diagnostic technologies, including molecular assays and automated blood typing systems. These next-generation immunohematology devices help enhance the effectiveness of the diagnosis, reduce the time taken for analysis and the human error risk factors, and extend immediate care services to patients. Automated systems streamline processes such as cross-matching and antibody screening, which are critical for transfusion safety. For instance, in 2024, QuidelOrtho's VITROS syphilis assay received FDA-clearance, offering automated detection of Treponema pallidum antibodies on VITROS systems (3600, 5600, XT 7600), now globally available, enhancing infectious disease diagnostics. Additionally, molecular diagnostics allow for precise genotyping, aiding in the identification of rare blood groups and antibodies that traditional methods might overlook. Healthcare providers are increasingly adopting these technologies to meet the growing demand for high-quality and rapid diagnostic solutions, particularly in developed markets where healthcare infrastructure supports sophisticated equipment.

Expanding Focus on Personalized Medicine and Rare Blood Disorders

Another emerging trend in the immunohematology market is the growing emphasis on personalized medicine, particularly for individuals with rare blood disorders. Advances in genomic research have paved the way for tailored therapies and precise blood transfusion practices. The identification of unique antigen profiles and rare phenotypes is becoming increasingly important, especially in regions with diverse populations. For instance, in 2024, clinical-stage radiopharmaceutical company CU6 is advancing next-generation theragnostic products using its SAR Technology platform. The company announced promising Phase I/II trial data from the COBRA study. The trial confirmed that its copper-based imaging agent, I64Cu-SAR-bisPSMA, is safe and also highly effective in detecting prostate cancer lesions in patients with biochemical recurrence. By integrating targeted imaging with therapeutic capabilities, this technology could enhance diagnostic accuracy and enable personalized treatment strategies in immunohematology. As awareness of rare blood conditions rises, demand for specialized immunohematology products and services is anticipated to grow, highlighting the market's expanding role in precision healthcare.

Immunohematology Industry Segmentation:

Analysis by Product:

  • Analyzing Systems
  • Reagents and Consumables

Reagents and consumables stand as the largest product in 2024, holding around 65.5% of the market. This large share underlines their critical role in blood typing, antibody screening, and crossmatching procedures that are necessary for transfusion safety and compatibility testing. These products are essential for achieving accurate results in diagnostic laboratories, blood banks, and hospitals. The increasing incidence of chronic and infectious diseases, together with a rise in blood donation activities, adds to the market demand for reagents and consumables. Moreover, the advancement in diagnostic technologies and introduction of high-performance reagents enhance their adoption. This segment's dominance positions it to meet a rising global need for reliable and efficient immunohematology testing solutions.

Analysis by Technology:

  • Biochips
  • Gel Cards
  • Microplates
  • Polymerase Chain Reaction
  • Erythrocyte-Magnetized Technology (EMT)
  • Others

Polymerase chain reaction leads the market with around 38.5% of the market share in 2024. Its dominance underscores its critical role in diagnostics, research, and therapeutic applications. PCR's precision in amplifying DNA and RNA sequences makes it a cornerstone technology for detecting infectious diseases, genetic mutations, and cancer markers. The increasing rate of chronic disease and an emphasis on earlier diagnosis make its widespread use popular among laboratories, clinics, and research institutions. Technological innovation such as the development of real-time PCR and digital PCR enhances its sensitivity and efficiency, creating further success in the marketplace. Finally, its emerging application fields such as in personalized medicine and pharmacogenomics has cemented its position as one of the more dominant technologies in the space of molecular diagnostics and research.

Analysis by Application:

  • Blood-Related Diseases
  • HIV
  • Hepatitis
  • Blood Transfusion
  • Others

HIV lead the market in 2024. HIV stands as the leading application in the market, reflecting its critical importance in diagnostics, treatment monitoring, and research. The overall interest in the management of HIV/AIDS around the world increases the adoption of advanced diagnostic technologies to enable early detection, viral load monitoring, and antiretroviral therapy efficacy. The rise in the incidence of HIV in underserved areas further escalates the demand for effective testing solutions. Innovations such as point-of-care diagnostics and molecular technologies further facilitate efficient and accurate results. Moreover, the government's initiatives and funds for eradicating HIV enhance market growth. The application leadership has indicated its importance in public health endeavors, improved patient outcomes, and facilitating research toward efficient prevention and cure strategies.

Analysis by End-User:

  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories
  • Others

Hospitals lead the market with around 23.8% of the market share in 2024. Hospitals are leading centers for diagnostic procedures, interventions for therapeutic management, and treatment and care. These institutions thus account for the highest number of the market share. A higher need for proper and timely diagnostics of chronic as well as acute diseases promotes the acceptance of advanced technology within the hospitals. Moreover, the increasing incidence of complex diseases and the requirement for state-of-the-art facilities for the comprehensive management of patients contribute to this segment's dominance. Hospitals have the advantage of a high volume of patients, infrastructure, and multidisciplinary expertise, which allows them to provide consistent and efficient services, thereby making them a strong market segment.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 40.2%. The dominance of this region is attributed to advanced healthcare infrastructure, strong research and development activities, and high adoption of novel diagnostic and therapeutic technologies. Leadership in the region is also boosted by increased government funding for healthcare initiatives, strong presence of key industry players, and increased demand for advanced medical devices and diagnostics. High level of awareness and access to advanced treatment is a major contributor toward the region's pre-eminent market position. Furthermore, chronic and infectious disease prevalence, coupled with a well-developed regulatory system, encourages the use of advanced health care delivery solutions. It, therefore, points out that North America is an innovation, investment, and development hub in the health and life sciences industries.

Key Regional Takeaways:

United States Immunohematology Market Analysis

US accounts for 73.5% share of the market in North America. The United States market is largely driven by advances in healthcare infrastructure and an increase in demand for blood transfusion services. According to the CDC, 1 in 76 Americans is affected by a blood disorder, creating demand for immunohematology testing. Sickle cell anemia, thalassemia, and hemophilia are some of those that have received diagnostic monitoring and blood management for a prolonged period. The aging population and increasing prevalence of chronic diseases are additional factors increasing the demand for blood transfusions. Cutting-edge immunohematology technologies, especially automated blood-typing and crossmatching systems, increase accuracy of diagnosis and help the growth of the market. Government initiatives directed toward building blood safety standards and regulations provide an essential impetus for the growth of the market. Further, the rise of personalized medicine and genetic testing boosts the adoption of advanced immunohematology products. The increasing demand for high-quality blood products and greater emphasis on donor screening augment market growth. A healthy presence of major companies together with ongoing efforts to enhance blood-testing techniques signifies that the U.S. market is ready for great development, confronting healthcare problems and ensuring transfusion safety.

Asia Pacific Immunohematology Market Analysis

The Asia-Pacific immunohematology market mainly benefited from the growing healthcare needs of an aging population and increasing prevalence of chronic diseases. According to the WHO, noncommunicable diseases (NCDs), especially those of cardiovascular, cancer, diabetes, and chronic respiratory diseases, account for 62% of all deaths in the South-East Asia Region, affecting 9 Million people. The premature mortality from NCDs is a matter of grave concern, with a very notable portion of these deaths occurring before the age of 70. This rising burden of NCDs leads to a growing demand for blood transfusions or immunohematology services. Rapid advancements in medical technology, together with enhanced healthcare investments in the emerging economies of China and India, will further aid market expansion. Moreover, advanced immunohematology technologies, including automation in blood typing and compatibility testing, immensely accelerate their adoption in the region.

Europe Immunohematology Market Analysis

The immunohematology market in Europe is influenced by factors such as a growing need for blood transfusions, improving of tests for diagnosis, and increased patient population base with chronic blood disorders. As per the European Commission on January 1, 2023, the population of the EU was approximately estimated to be 448.8 Million, with 21.3% above 65 years, representing an increase of 0.2% points from the last year and 3.0% points over the last one decade. Changes in demographics point toward higher healthcare needs when it comes to managing age-related blood issues. The high prevalence of cardiovascular diseases and other chronic conditions in older populations further strengthens the need for immunohematology services. Europe's emphasis on blood safety standards because of stringent regulatory frameworks encourages the adoption of innovative immunohematology products. The availability of advanced technologies such as molecular blood group typing and automated crossmatching systems increases the present market opportunity. Government efforts to improve healthcare services and ensure safe blood transfusions also aid in market growth. The presence of key industry players and ongoing research to improve the accuracy of testing and safety during transfusion ensure continued growth for the immunohematology market in Europe.

Latin America Immunohematology Market Analysis

In Latin America, the immunohematology market is driven by increased healthcare access and blood safety awareness. A PubMed Central study states that 100,000 - 150,000 Latin Americans are afflicted with sickle cell disease (SCD), leading to an increase in blood transfusions and immunohematology services. The prevalence of SCD and thalassemia calls for advanced diagnostic solutions. Improvements in healthcare standards, driven by government initiatives and blood donation programs, also support market growth. Moreover, there is a rising demand for accurate blood screening and testing solutions, as healthcare providers are focusing on better blood transfusion safety and reliability.

Middle East and Africa Immunohematology Market Analysis

The immunohematology market, driven by infrastructural improvements in healthcare, increased investment in biotechnology, and increasing awareness of blood-related safety issues, will grow in the Middle East and Africa area. According to PubMed Central, 30% of the people in the Middle East who suffer from anemia are primarily women, mostly due to iron deficiency or other causes. The high prevalence of blood disabilities such as SCD and thalassemia enables the need for blood transfusions and immunohematology services. Government initiatives to develop the healthcare systems in the region and to ensure that blood products are safe and accurate contribute to regional market growth.

Competitive Landscape:

The immunohematology market is characterized by intense competition among key players focused on innovation, collaborations with key partners, and expansion into new regions to enhance their market footprint. Prominent companies lead the market by offering a broad range of products, including blood typing reagents, analyzers, and software solutions. These players heavily invest in research and development to introduce advanced technologies, such as fully automated systems and molecular diagnostic tools, that enhance testing accuracy and efficiency. Strategic mergers, acquisitions, and collaborations are common, enabling companies to expand their product portfolios and gain access to new markets. Additionally, the presence of regional and local players contributes to market competitiveness, particularly in emerging economies. The growing emphasis on cost-effective and high-quality diagnostics drives innovation, while regulatory compliance and certifications remain key differentiators. For instance, in 2024, Abbott and Big Ten's "We Give Blood Drive" inspired nearly 20,000 donations, saving 60,000 lives, alleviating blood shortages, and contributing to the collection of blood essential for life-saving transfusions and immunohematology research. The competitive landscape is further shaped by increasing demand for personalized healthcare and enhanced transfusion safety.

The report provides a comprehensive analysis of the competitive landscape in the immunohematology market with detailed profiles of all major companies, including:

  • Abbott
  • Antisel
  • BD (Becton Dickinson and Company)
  • Beckman Coulter Inc. (Danaher Corporation)
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Grifols S.A.
  • Merck KGaA
  • MTC Invitro Diagnostics AG
  • Ortho-Clinical Diagnostics Inc (The Carlyle Group)
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What is Immunohematology?
  • 2.How big is the Immunohematology market?
  • 3.What is the expected growth rate of the global Immunohematology market during 2025-2033?
  • 4.What are the key factors driving the global Immunohematology market?
  • 5.What is the leading segment of the global Immunohematology market based on the product?
  • 6.What is the leading segment of the global Immunohematology market based on technology?
  • 7.What is the leading segment of the global Immunohematology market based on application?
  • 8.What is the leading segment of the global Immunohematology market based on end user?
  • 9.What are the key regions in the global Immunohematology market?
  • 10.Who are the key players/companies in the global Immunohematology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunohematology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Analyzing Systems
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Biochips
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gel Cards
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Microplates
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Polymerase Chain Reaction
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Erythrocyte-Magnetized Technology (EMT)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Blood-Related Diseases
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 HIV
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hepatitis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Blood Transfusion
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Blood Banks
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diagnostic Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Antisel
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 BD (Becton Dickinson and Company)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Bio-Rad Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Grifols S.A.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 MTC Invitro Diagnostics AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Ortho-Clinical Diagnostics Inc (The Carlyle Group)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 SWOT Analysis
    • 14.3.11 Siemens Healthcare GmbH
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Immunohematology Market: Major Drivers and Challenges
  • Figure 2: Global: Immunohematology Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Immunohematology Market: Breakup by Product (in %), 2024
  • Figure 4: Global: Immunohematology Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Immunohematology Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Immunohematology Market: Breakup by End-User (in %), 2024
  • Figure 7: Global: Immunohematology Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Immunohematology Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Immunohematology (Analyzing Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Immunohematology (Analyzing Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Immunohematology (Reagents and Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Immunohematology (Reagents and Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Immunohematology (Biochips) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Immunohematology (Biochips) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Immunohematology (Gel Cards) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Immunohematology (Gel Cards) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Immunohematology (Microplates) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Immunohematology (Microplates) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Immunohematology (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Immunohematology (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Immunohematology (Erythrocyte-Magnetized Technology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Immunohematology (Erythrocyte-Magnetized Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Immunohematology (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Immunohematology (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Immunohematology (Blood-Related Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Immunohematology (Blood-Related Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Immunohematology (HIV) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Immunohematology (HIV) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Immunohematology (Hepatitis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Immunohematology (Hepatitis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Immunohematology (Blood Transfusion) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Immunohematology (Blood Transfusion) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Immunohematology (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Immunohematology (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Immunohematology (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Immunohematology (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Immunohematology (Blood Banks) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Immunohematology (Blood Banks) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Immunohematology (Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Immunohematology (Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Immunohematology (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Immunohematology (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: North America: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: North America: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: United States: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: United States: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Canada: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Canada: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Asia Pacific: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Asia Pacific: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: China: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: China: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Japan: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Japan: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: India: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: India: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: South Korea: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: South Korea: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Australia: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Australia: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Indonesia: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Indonesia: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Others: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Others: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Europe: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Europe: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Germany: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Germany: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: France: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: France: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: United Kingdom: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: United Kingdom: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Italy: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Italy: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Spain: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Spain: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Russia: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Russia: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Latin America: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Latin America: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Brazil: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Brazil: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Mexico: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Mexico: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Others: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Others: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Middle East and Africa: Immunohematology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Middle East and Africa: Immunohematology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Global: Immunohematology Industry: SWOT Analysis
  • Figure 92: Global: Immunohematology Industry: Value Chain Analysis
  • Figure 93: Global: Immunohematology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunohematology Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Immunohematology Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Immunohematology Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Immunohematology Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Immunohematology Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 6: Global: Immunohematology Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Immunohematology Market: Competitive Structure
  • Table 8: Global: Immunohematology Market: Key Players